CooperVision: When Is an Agreed Price Not Market Value?

The recent First-tier Tribunal decision in CooperVision Lens Care Ltd v HMRC has already prompted considerable discussion among tax advisers, principally because of its conclusions on the employment-related securities legislation.

Much of that commentary has focused on whether the relevant shares were employment-related securities and whether part of the sale proceeds should therefore have been taxed as employment income rather than capital gains.

This article does not revisit those issues.

Instead, it considers a point of broader and more enduring interest to valuation practitioners: the Tribunal's treatment of market value, and its approach to carelessness where a taxpayer relies on an independent valuation founded on an inaccurate factual premise.

Background

CooperVision Lens Care Ltd (formerly Sauflon Pharmaceuticals Ltd) was sold to CooperVision Holdings (UK) Ltd (“CV”) in 2014 for a total consideration of approximately £665 million, subject to debt adjustments. The transaction was negotiated at arm's length between two unconnected parties.

The dispute was not about the headline price paid by the buyer. It was about how that price was allocated among the selling shareholders.

Two directors and a spouse, referred to as the “majority shareholders”, received a materially higher price per share than the other sellers, notwithstanding that the shares ranked equally on a sale. The remaining sellers comprised five management shareholders and two private capital shareholders.

HMRC's case was that the shares should be valued on the basis that they ranked equally on a sale, so that any amount received above a pro rata figure was not market value for tax purposes. To the extent the shares were employment-related securities, the excess was therefore potentially taxable as employment income.

The appellant's case was that the different prices reflected genuine negotiations between the selling shareholder groups and that those agreed amounts were the best evidence of market value for each parcel of shares. On that analysis, each shareholder had secured the best price available for their own shares, and the differences in outcome were simply a product of the market.

Market value

For tax purposes, market value is determined under sections 272 and 273 of the Taxation of Chargeable Gains Act 1992. In broad terms, it is the price the assets might reasonably be expected to fetch on a sale in the open market, assuming a hypothetical willing buyer and a hypothetical willing seller, both acting at arm's length.

The Tribunal approached the question by asking what a hypothetical buyer would pay for the shares, having regard to the rights attaching to them and the relevant facts at the valuation date. It was not enough to point to the price actually agreed between different shareholder groups and say that this must, by itself, be market value.

On the facts, the Tribunal found that:

• CV agreed to acquire all of the shares in the company for around £665 million, subject to adjustment, and negotiated that price with the two directors, not with the other shareholders directly.
• CV was not concerned with the internal split of the proceeds between the sellers.
• The division of the total price between the shareholder groups was negotiated separately, without CV's involvement.
• Those discussions took place between sellers, not between a buyer and a seller, so the factors relied on in the allocation were not necessarily matters that a hypothetical buyer would regard as relevant.
• Given these circumstances, the Tribunal concluded that the shares acquired by CV were of equal value to CV immediately after completion.

That conclusion matters because the Tribunal treated the differential allocation of proceeds as reflecting matters personal to the selling shareholders, rather than value inherent in the shares themselves.

The distinction is important. Valuation practitioners frequently encounter transactions where commercial negotiations produce outcomes influenced by factors unique to particular shareholders. CooperVision suggests that practitioners should distinguish carefully between value that is inherent in the shares and value that arises from the negotiating position of a particular holder.

The appellant also relied on expert valuation evidence. In substance, that evidence sought to support the proposition that because each shareholder had agreed to receive a particular amount under the transaction documents, and because the allocations had been negotiated on arm's-length terms between the seller groups, those prices should be accepted as market value.

The Tribunal rejected that approach. The majority shareholders were not acting as hypothetical buyers would act, and the factors relied upon in the allocation negotiations were not those a hypothetical purchaser would take into account in valuing the shares.

Market value remains an objective statutory concept. Negotiated prices may be compelling evidence, but they cannot be accepted uncritically without considering whether the factors influencing those negotiations are ones that a hypothetical purchaser would recognise.

Why that matters

The value of the decision lies in its distinction between a genuine market valuation and a negotiated allocation of proceeds. A hard-fought commercial negotiation between shareholders is not the same thing as an open market sale.

That distinction is especially important where the buyer is indifferent to the split between sellers. If the purchaser cares only about the price for the whole company, an internal reallocation between shareholders may be commercially real, but it does not necessarily answer the statutory question of what the shares were worth in the hands of a hypothetical buyer.

For valuation practitioners, the case is therefore a reminder that contractual allocations are not automatically valuation evidence. They may be relevant, but they do not displace the need to test whether the result actually reflects market value.

Carelessness

The Tribunal also found the appellant careless. From a valuation perspective, that finding is an important reminder that the quality of a valuation is dependent on the quality of the factual instructions received. Even an otherwise technically reasonable methodology cannot compensate for an inaccurate understanding of the underlying transaction.

A valuation letter and memorandum had been prepared by the sellers' advisers at the time of the transaction. The Tribunal held that these materials did not reflect the actual commercial negotiations. They proceeded on a structure involving two sale and purchase agreements with CV and on the premise that there had been separate commercial negotiations between CV and different shareholder groups.

Despite reviewing those materials, the Tribunal found that the taxpayer had not applied the critical scrutiny that would have been expected. In particular, it should have recognised that the factual assumptions underlying the valuation did not match the reality of the transaction. The tribunal found the advice provided in the memo and valuation letter to be unreliable.

The Tribunal also considered that a reasonable taxpayer would have sought specialist advice on the PAYE issue from a suitably qualified adviser, having first provided that adviser with all relevant information about the negotiations. On that basis, the Tribunal found the taxpayer careless.

That is a useful warning in its own right. A valuation can be professionally presented and still prove vulnerable if its factual basis is wrong or incomplete. If the underlying transaction is not accurately described, the risk is not only that the valuation is wrong, but also that reliance on it may later be judged careless.

Practical takeaways

For valuation practitioners, the case points to four practical lessons:

• A headline transaction with a single buyer and a single aggregate price does not automatically justify treating different seller-side allocations as separate market values.
• A hard-fought negotiation between sellers is not the same thing as a hypothetical open market sale.
• Valuations are only as strong as the facts on which they are built. If the assumptions do not match the commercial reality, the analysis may not survive scrutiny.
• Taxpayers are better protected when they obtain advice that directly addresses the tax question, rather than relying on valuation work prepared for a different purpose or for another party.

The broader takeaway is that CooperVision is not simply a case about employment-related securities. It is also a reminder that, in tax valuations, form and substance must be aligned. Where they are not, both the valuation and the taxpayer's reliance on it may come under pressure.

Cases such as CooperVision also illustrate that valuation evidence rarely exists in isolation. Valuation practitioners must understand not only the financial characteristics of the shares being valued, but also the legal rights attaching to those shares and the commercial context in which the transaction occurred. The strongest valuation opinions are often those that integrate legal analysis, commercial evidence and valuation methodology into a coherent explanation.